files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 18, Issue 11 (2024)

References

  1. Elnahry, A.G., A.A. Abdel-Kader, A.E. Habib, G.A. Elnahry, K.A. Raafat and K. Elrakhawy, 2020. Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Rev. Recent Clin. Trials, 15: 1-10.
  2. Golshani, C., T.F. Conti, F.F. Conti, F.Q. Silva and A. Rachitskaya et al., 2020. Diabetic Macular Edema Treated With Intravitreal Aflibercept Injection After Treatment With Other Anti-VEGF Agents (SWAP-TWO Study)—12-Month Analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. VitreoRetinal Dis., 4: 1-10.
  3. Chatziralli, I., D. Kazantzis, G. Theodossiadis, P. Theodossiadis and T.N. Sergentanis, 2021. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmic Res., 64: 1-10.
  4. Babiuch, A.S., T.F. Conti, F.F. Conti, F.Q. Silva, A. Rachitskaya, A. Yuan and R.P. Singh, 2019. Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Retina Vitreous, Vol. 5. 10.1186/s40942-019-0167-x 1-10.
  5. Lattanzio, R., M.V. Cicinelli and F. Bandello, 2017. Intravitreal Steroids in Diabetic Macular Edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Dev.s Ophthalmol., 60: 1-10.
  6. Wells, J.A., A.R. Glassman, A.R. Ayala, L.M. Jampol and N.M. Bressler et al., 2016. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology, 123: 1-10.
  7. Avery, R.L., A.A. Castellarin, N.C. Steinle, D.S. Dhoot and D.J. Pieramici et al., 2017. SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Retina, 37: 1-10.
  8. Introini, U. and G. Casalino, 2017. Intravitreal Aflibercept in Diabetic Macular Edema: Long-Term Outcomes. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Dev.s Ophthalmol., 60: 1-10.
  9. Banaee, T., M. Ashraf, F.F. Conti and R.P. Singh, 2017. Switching Anti-VEGF Drugs in the Treatment of Diabetic Macular Edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmic Surg., Lasers Imaging Retina, 48: 1-10.
  10. Colucciello, M., 2015. Current intravitreal pharmacologic therapies for diabetic macular edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Postgraduate Med., 127: 1-10.
  11. Tripathy, K., Y. Sharma, K. R, R. Chawla and V. Gogia et al., 2015. Recent Advances in Management of Diabetic Macular Edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Curr. Diabetes Rev., 11: 1-10.
  12. Mehta, H., C. Hennings, M.C. Gillies, V. Nguyen, A. Campain and S. Fraser-Bell, 2018. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Cochrane Database Syst. Rev., Vol. 4. 10.1002/14651858.cd011599.pub2 1-10.
  13. Garoon, R.B., R.E. Coffee, L. Jiang, C.Y. Weng and P.E. Carvounis, 2016. Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Ophthalmol., Vol. 2016. 10.1155/2016/5282470 1-10.
  14. Habib, M.S., 2018. ILUVIEN ® Technology in the Treatment of center-involving Diabetic Macular edema: A Review of the Literature. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ther. Delivery, 9: 1-10.
  15. Dervenis, N., A.M. Mikropoulou, P. Tranos and P. Dervenis, 2017. Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Adv. Ther., 34: 1-10.
  16. Boyer, D.S., J.J. Hopkins, J. Sorof and J.S. Ehrlich, 2013. Anti-vascular endothelial growth factor therapy for diabetic macular edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ther. Adv. Endocrinol. Metab., 4: 1-10.